Exelixis
EXEL
#1660
Rank
NZ$22.72 B
Marketcap
NZ$91.72
Share price
3.58%
Change (1 day)
46.45%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company